Allergan Inc. (AGN) News Nov 17, 2014, 7:55

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Allergan Inc. (AGN) News Nov 17, 2014, 7:55 p.m.
MarketWatch News on AGN
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Today - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Today - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Today - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Today - The Trading Deck
Newscast: It's Merger Mania Monday 9:57 a.m. Today - MarketWatch
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Today - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Today - Ciara Linnane
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop 9:24 a.m. Today - MarketWatch
Actavis, Allergan close to a deal 8:33 a.m. Today - Jonathan D. Rockoff
Allergan's stock jumps 4.2% premarket after report of potential merger deal 8:22 a.m. Today - Tomi Kilgore
Allergan near a buyout deal worth up to 65 billion 4:30 a.m. Today - MarketWatch
Allergan, Actavis near cash-and-stock deal: WSJ 1:48 p.m. Nov. 16, 2014 - Andria Cheng
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Aegon profit hit by mortality changes 2:14 a.m. Nov. 13, 2014 - MarketWatch.com
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Bill Ackman scores critical win in Valeant-Allergan takeover war 4:23 p.m. Nov. 4, 2014 - Russ Britt
Regeneron skids on shortfall in Eylea sales 11:15 a.m. Nov. 4, 2014 - Russ Britt
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Loading more headlines...
Advertisement
Other News on AGN
Jim Cramer's 'Mad Money' Recap: When Bad News Is Really Good News for Us 8:09 p.m. Today - TheStreet.com
Deal Boom Feeds on Surging Stocks 7:33 p.m. Today - The Wall Street Journal Interactive Edition
Actavis to Buy Allergan for $66 Billion 7:24 p.m. Today - The Wall Street Journal Interactive Edition
Jack Lew, Irish Hero 7:06 p.m. Today - The Wall Street Journal Interactive Edition
Merck Updates on Anti-PD-1 Drug Keytruda Phase II Study - Analyst Blog 6:30 p.m. Today - Zacks.com
Bristol-Myers Squibb Reports Positive Opdivo Phase III Data - Analyst Blog 6:20 p.m. Today - Zacks.com
Here Are Some Big Caps Poised To Make Gains 5:45 p.m. Today - Investors Business Daily
Five Ethical Drugmakers Keep Leadership Positions 5:27 p.m. Today - Investors Business Daily
Actavis' $66 Bil Offer Steals Allergan From Valeant 4:31 p.m. Today - Investors Business Daily
Stock Market Today: Japan Recession Keeps Markets From Celebrating Deals Deluge 4:15 p.m. Today - TheStreet.com
Actavis-Allergan Deal Paves Way for Tax Savings 1:38 p.m. Today - The Wall Street Journal Interactive Edition
Stock Market Today: Stocks Are Mixed as Corporate Deals Offset Japan's Recession 1:16 p.m. Today - TheStreet.com
Pershing Square wins big on Actavis buy 12:22 p.m. Today - Seeking Alpha
Cramer: Investors Should Ignore Analysts' Calls on Hotel, Other Stocks 11:32 a.m. Today - TheStreet.com
Allergan's $66 Billion Actavis Deal is Still a Win for Bill Ackman 10:59 a.m. Today - TheStreet.com
Benzinga's Volume Movers 9:29 a.m. Today - benzinga.com
Actavis Nabs Allergan For $66 Billion; Valeant Folds 9:17 a.m. Today - Investors Business Daily
Actavis plc Buying Allergan In $66 Billion Deal 9:06 a.m. Today - benzinga.com
Actavis (ACT) to Buy Botox Maker Allergan (AGN) 7:41 a.m. Today - InvestorPlace.com
Invest Like Kim Kardashian - Investment Ideas 4:09 a.m. Today - Zacks.com
Loading more headlines...
Press Releases on AGN
Fitch: Allergan Purchase by Actavis Would Pressure Ratings 1:44 p.m. Today - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Allergan Acquisition Announcement; Outlook Stable 12:20 p.m. Today - BusinessWire - BZX
ALLERGAN SHAREHOLDER ALERT:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Actavis 11:16 a.m. Today - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:32 a.m. Today - PR Newswire - PRF
Valeant Comments On Allergan Announcement 9:29 a.m. Today - PR Newswire - PRF
Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue 9:15 a.m. Today - PR Newswire - PRF
Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community 9:00 a.m. Nov. 14, 2014 - BusinessWire - BZX
FDA Approves New Styles of Allergan’s NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 4:50 p.m. Nov. 12, 2014 - BusinessWire - BZX
Allergan Board of Directors Announces Approval of Amendments to Company’s Bylaws 7:02 a.m. Nov. 12, 2014 - BusinessWire - BZX
New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX® Cosmetic (onabotulinumtoxinA) 8:47 a.m. Nov. 11, 2014 - PR Newswire - PRF
Ad hoc: Biofrontera to take over the sales and marketing of Ameluz(R) in Spain from Allergan 3:20 a.m. Nov. 7, 2014 - Thomson Reuters ONE
New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Looking Body(1) 4:25 p.m. Nov. 5, 2014 - PR Newswire - PRF
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology 9:37 a.m. Nov. 5, 2014 - BusinessWire - BZX
Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square 1:56 p.m. Nov. 4, 2014 - BusinessWire - BZX
Valeant And Pershing Square May Vote At Special Meeting 1:27 p.m. Nov. 4, 2014 - PR Newswire - PRF
Quarterly Financial & Operational Results Release and Dividends - Research Reports on AFLAC, BlackRock, Allergan, Cabot and Cheniere Energy 8:40 a.m. Nov. 3, 2014 - PR Newswire - PRF
Allergan Canada Launches a 3D JUVEDERM(R) Visualization iPad App Powered by ModiFace 9:02 a.m. Oct. 29, 2014 - Marketwired
Allergan Comments on Valeant Letter 9:10 a.m. Oct. 27, 2014 - BusinessWire - BZX
Allergan Announces Quarterly Conference Call 1:00 p.m. Oct. 24, 2014 - BusinessWire - BZX
Global Pediatric Drugs and Vaccines Market 5:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Loading more headlines...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 184

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 159

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
Airtel Money Upgrade Raises the Stakes in East Africa

Updated Category News Views 0

Mobile money lives or dies in the irritating little moments: a transfer that hangs, a menu that makes people punch five buttons too many, a merchant payment that simply will not clear. Airtel Money is attacking that friction in Malawi and Tanzania with an enhanced platform from Comviva, and this is more consequential than the usual software-refresh chest thumping. In...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 197

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Max y Noelia Explore Trade at 9th CIIE in Shanghai

Updated Category News Views 126

Influencers at the Heart of Global Trade Exploration Makin' their debut on the big stage of the 9th China International Import Expo (CIIE), Mexican influencers Max y Noelia found themselves caught in a whirlwind of trade and cultural exchanges over in Shanghai. These digital mavens aren't just snapping selfies. Nope, they're capturing the very essence of international...

Continue Reading
Vusion's 2030 Plan Puts Recurring Revenue First At Scale

Updated Category News Views 20

Shelf labels are not exactly romance, yet Vusion has turned them into a serious growth machine. The 2030 plan is not really about hanging more electronic displays in aisles; it is about making those displays, sensors and store connections produce software and service revenue for years. That is the part of this story worth watching. The Hardware Base Is Becoming the Hook...

Continue Reading
Tim Hortons Bets on ELF Cheer for U.S. Holiday Visits

Updated Category News Views 0

Nothing says holiday restaurant marketing quite like putting spaghetti-shaped whipped topping on hot chocolate and trusting a 2003 movie to do the selling. Tim Hortons is rolling out an ELF-inspired menu at participating U.S. locations starting November 18, 2026, pairing the chain with Warner Bros. Consumer Products and mining Buddy the Elf's sugar-fueled world for a...

Continue Reading
Unisys Opens Its 2027 Innovation Program Across India

Updated Category News Views 147

Talent pipelines rarely make the market’s pulse race, but they can expose whether a tech firm is still trying to build for the next turn. Unisys has opened registration for the 2027 Unisys Innovation Program, its eighteenth annual technical competition for engineering students in India. For a company selling cloud, AI, digital workplace, applications and enterprise...

Continue Reading
Sectra's RSNA AI Pitch Centers on Workflow, Not Hype

Updated Category News Views 95

Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...

Continue Reading
Markel Elevates War Risk Expertise in London Market

Updated Category News Views 67

A Specialty Desk Gets Its Own Weather Vane War and political violence underwriting is not a corner of insurance where a fancy title change can be shrugged off. The ground shifts under the policyholder, the broker and the carrier without much warning, and a bad call can sit on a book for years. Markel Insurance has named Chloe Gordge Director of War and Political Violence...

Continue Reading

Top 5 Most Recently Viewed Articles

Dover Set to Release Q2 2025 Earnings; Join the Conference Call

Updated Category News Views 156

Dover Set to Release Q2 2025 Earnings Dover is gearing up to share its financial results for the second quarter of 2025, scheduled for release at approximately 6:00 a.m. Central time on the upcoming Thursday. This significant event marks a crucial moment for shareholders and analysts alike, as they anticipate insights into the company's performance and strategic moves....

Continue Reading
Investigation of ImmunityBio, Inc. and Shareholder Rights

Updated Category News Views 322

Investigation of ImmunityBio, Inc. In recent developments, Bragar Eagel & Squire, P.C., a well-respected law firm specializing in shareholder rights, has launched an investigation regarding ImmunityBio, Inc. (NASDAQ: IBRX). This probe is geared towards looking into potential legal claims on behalf of long-term shareholders, aiming to ensure their interests are safeguarded...

Continue Reading
Norges Bank's Recent Stake Change in Syensqo Explained

Updated Category News Views 279

Norges Bank's Recent Notification Regarding Stake in Syensqo Norges Bank has recently communicated a significant change regarding its participation in Syensqo. This notification, in line with Belgian transparency laws, reveals that Norges Bank has crossed the 3% voting rights threshold, which is vital for all stakeholders. Understanding the Changes in Voting Rights The...

Continue Reading
ZyVersa Therapeutics Marks Progress with Promising Pipeline Updates

Updated Category News Views 232

Key Developments in ZyVersa's Clinical Journey Important Highlights: Announcement of a Phase 2a proof-of-concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 focusing on patients with diabetic kidney disease planned for the first half of 2025. The regulatory framework for VAR 200’s primary indication, focal segmental glomerulosclerosis (FSGS), is set to...

Continue Reading
Bunion Surgery Market Growth and Leading Players Explained

Updated Category News Views 270

Overview of the Bunion Surgery Market The global Bunion Surgery Market is witnessing substantial growth, projected to increase from US$437.8 million in 2023 to an impressive US$606.1 million by 2029, achieving a CAGR of 5.7%. The surge in demand for surgical treatments primarily arises from the rising incidence of bunions, particularly among the aging population who are...

Continue Reading